USPTO serial 76447468
PEPMED
Reviewed by CopyMark Law Group
Reg. 2870897Status 710
- Filing date
- Status date
- Registration date
- Aug 10, 2004
- Examiner
- JOHNSON, AISHA CLARKE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with PEPMED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
10115 Berlin, DE
10115 Berlin, DE
10115 Berlin, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew J. Smith
Brian B. Diekhoff Polsinelli Shughart PC100 South Fourth StreetSuite 1000St. Louis, MO 63102Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the manufacture of pharmaceuticals; carrier materials comprised of nucleic acids, peptides and proteins for research purposes, for pharmaceutical research, for diagnostic purposes for scientific research, for biochemical research purposes in the field of antibody epitope mapping, proteine/proteine interaction, and enzyme profiling | SECTION 8 - CANCELLED | — |
| 005 | Human and veterinary pharmaceutical preparations for the treatment of illnesses caused by defects in signal transduction cascades, namely cancer, neurodegenerative diseases, allergic diseases and cardiovascular diseases, comprised of amino acids, nucleic acids, peptides, proteins and peptidomimetics; carrier materials comprised of nucleic acids, peptides and proteins for diagnostic purposes for medical treatments | SECTION 8 - CANCELLED | — |
| 009 | Scientific measuring and checking apparatus and instruments, namely micro-array scanner comprised of filters and cellulose or polypropylene membranes for use in the field of biotechnology, pharmacology and for use in pharmaceutical research; analytical device, namely robot, synthesizer, spotter and nanoplotter for non-medical purposes, comprised primarily of computer programs for synthesis and immobilization of chemicals, for the analysis of patterns on surfaces, and for the screening of chemical compounds | SECTION 8 - CANCELLED | — |
| 010 | Analytical device, namely nanoplotter for medical purposes, comprised primarily of computer programs for synthesis and immobilization of chemicals, for the analysis of patterns on surfaces, and for the screening of chemical compounds | SECTION 8 - CANCELLED | — |
| 040 | Custom synthesis of chemicals used in industry and science for third parties; custom immobilization of arrays of chemicals compounds for others; custom modification of peptides and proteins for others; and custom transformation of chemical compounds for others | SECTION 8 - CANCELLED | — |
| 042 | Scientific research, namely immobilization of arrays of chemical compounds, modification of peptides and proteins, transformation of chemical compounds; scientific and technological services and research as well as designer services for third parties in the field of biotechnology and pharmaceuticals, namely development of new technology for others; industrial analysis and research services in the field of biotechnology and pharmaceuticals, namely synthesis and immobilization of chemicals used in industry and science, screening for interaction partners, antibody epitope mapping, proteine/proteine interaction, and enzyme profiling; design and development of computer hardware and software; scientific research in the field of synthesis and immobilization of chemicals use in industry and science; chemical research, namely screening for chemical interactions of enzymes, enzyme substrates, antigens and antibodies; development of inhibitors of receptors and enzymes, namely, kinases, oxydoreductases, transerases, hydrolases, lyases, isomerases, and ligases; research and development of diagnostic assays, assays for pharmaceutical drug discovery and assays for target validation, namely methods for antigene detection and enzyme substrate identification for others; product research and development of chemicals used in industry and science; computer programming for other for the herein aforementioned purposes; agricultural research; scientific research; industrial design; computer programming for others; chemist, biologist, biochemist, gene technologist, molecular biologist, pharmacology, and physicist services | SECTION 8 - CANCELLED | — |
| 044 | Human and veterinary medical services; pharmaceutical advice; physician services; veterinary services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Jerini AG
- Other trademarks owned by Jerini AG
- Other trademarks owned by Jerini AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PEPMED
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 22, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 11, 2011 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Feb 3, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 3, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 24, 2007 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Oct 18, 2007 | PAPER RECEIVED | — | |
| Aug 11, 2004 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Aug 10, 2004 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 18, 2004 | PAPER RECEIVED | — | |
| May 18, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 28, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 3, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 24, 2004 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 24, 2004 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 23, 2004 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Aug 26, 2003 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 19, 2003 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Aug 6, 2003 | CFIT | CASE FILE IN TICRS | — |
| Jun 9, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 9, 2003 | PAPER RECEIVED | — | |
| Jan 6, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 9, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 26, 2002 | DOCK | ASSIGNED TO EXAMINER | — |